Aleafia Health Q1 Cannabis Net Revenue $13.7M, Up 183% QoQ

$13.7M cannabis net revenue, 183% increase over previous quarter, and 2,486% increase over prior year’s quarter
Positive cash flow from operations
85% gross margin on cannabis net revenue
3% increase SG&A expenses over previous quarter
$35M in cash, cash equivalents and marketable securities
Total liabilities decline by $7.9 million over Q4 2019
Fifth consecutive quarter reporting record revenue, second consecutive quarter of positive adjusted EBITDA
Adjusted EBITDA margin of 44%
Cash cost to produce per gram of $0.31

Insights